title: Extensive colonic ischemia following treatment with bevacizumab, fluouracil and CPT-11 in a young patient with advanced adenocarcinoma of the rectum.
authors.affiliation: Department of Surgery, Meir Medical Center, Kfar Saba, Israel. paranh@clalit.org.il
authors.forename: Haim
authors.initials: H
authors.lastname: Paran
authors.forename: Evgeny
authors.initials: E
authors.lastname: Edelstein
authors.forename: Baruch
authors.initials: B
authors.lastname: Klein
authors.forename: Mordechai
authors.initials: M
authors.lastname: Gutman
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols; D000068258:Bevacizumab; D002166:Camptothecin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D017091:Colitis, Ischemic / Q000139:chemically induced*; D003113:Colonoscopy; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D000077146:Irinotecan; D002955:Leucovorin; D008297:Male; D012004:Rectal Neoplasms / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000964:Antimetabolites, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D000068258:Bevacizumab; D000077146:Irinotecan; D002955:Leucovorin; D005472:Fluorouracil; D002166:Camptothecin